{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:51:11Z","timestamp":1790193071888,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Victorian Government's Operational Infrastructure Support Program"},{"name":"Baker IDI Bright Sparks PhD"},{"name":"RMIT University School of Medical Sciences"},{"name":"Australia Senior Research Fellow","award":["ID472673"],"award-info":[{"award-number":["ID472673"]}]},{"name":"Australia Senior Research Fellow","award":["ID1059960"],"award-info":[{"award-number":["ID1059960"]}]},{"name":"Endeavour Fellowship funded by the Australian Government"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.phrs.2015.12.006","type":"journal-article","created":{"date-parts":[[2015,12,30]],"date-time":"2015-12-30T17:46:28Z","timestamp":1451497588000},"page":"165-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["The HNO donor Angeli\u2019s salt offers potential haemodynamic advantages over NO or dobutamine in ischaemia\u2013reperfusion injury in the rat heart ex vivo"],"prefix":"10.1016","volume":"104","author":[{"given":"Kai Yee","family":"Chin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng Xue","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nga","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen L.","family":"Woodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca H.","family":"Ritchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2015.12.006_bib0005","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1001\/jama.296.18.2217","article-title":"Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure","volume":"296","author":"Gheorghiade","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2015.12.006_bib0010","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jjcc.2011.04.003","article-title":"Systolic blood pressure at admission, clinical manifestations, and in-hospital outcomes in patients with acute myocardial infarction","volume":"58","author":"Shiraishi","year":"2011","journal-title":"J. Cardiol."},{"key":"10.1016\/j.phrs.2015.12.006_bib0015","first-page":"e391-479","volume":"119","author":"Hunt","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2015.12.006_bib0020","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/eurjhf\/hfs033","volume":"14","author":"McMurray","year":"2012","journal-title":"Eur. J. Heart Fail"},{"key":"10.1016\/j.phrs.2015.12.006_bib0025","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1517\/14656566.7.16.2179","article-title":"Acute heart failure: inotropic agents and their clinical uses","volume":"7","author":"Endoh","year":"2006","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.phrs.2015.12.006_bib0030","first-page":"68","article-title":"Milrinone, dobutamine, and nitroprusside: comparative effects on hemodynamics and myocardial energetics in patients with severe congestive heart failure","volume":"73","author":"Monrad","year":"1986","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2015.12.006_bib0035","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0002-8703(99)70250-4","article-title":"Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST)","volume":"138","author":"O'Connor","year":"1999","journal-title":"Am. Heart J."},{"key":"10.1016\/j.phrs.2015.12.006_bib0040","first-page":"H753","article-title":"Effects of a novel inotropic agent, BAY y 5959, in conscious dogs: comparison with dobutamine and milrinone","volume":"272","author":"Sato","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.phrs.2015.12.006_bib0045","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1056\/NEJM197901043000105","article-title":"Dobutamine: a new synthetic cardioactive sympathetic amine","volume":"300","author":"Sonnenblick","year":"1979","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2015.12.006_bib0050","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1161\/CIRCHEARTFAILURE.113.000632","article-title":"Nitroxyl (HNO): a novel approach for the acute treatment of heart failure","volume":"6","author":"Sabbah","year":"2013","journal-title":"Circ. Heart Fail"},{"key":"10.1016\/j.phrs.2015.12.006_bib0055","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/ejhf.62","article-title":"Targeting myocardial remodelling to develop novel therapies for heart failure: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology","volume":"16","author":"Tarone","year":"2014","journal-title":"Eur. J. Heart Fail"},{"key":"10.1016\/j.phrs.2015.12.006_bib0060","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1111\/bph.12568","article-title":"The concomitant coronary vasodilator and positive inotropic actions of the nitroxyl donor Angeli's salt in the intact rat heart: contribution of soluble guanylyl cyclase-dependent and -independent mechanisms","volume":"171","author":"Chin","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2015.12.006_bib0065","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.1073\/pnas.0937302100","article-title":"Positive inotropic and lusitropic effects of HNO\/NO\u2014in failing hearts: independence from beta-adrenergic signaling","volume":"100","author":"Paolocci","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2015.12.006_bib0070","doi-asserted-by":"crossref","DOI":"10.2174\/1389450116666151001112020","article-title":"Invited review: new pharmacological approaches to the prevention of myocardial ischemia\u2013reperfusion injury","author":"Chin","year":"2015","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.phrs.2015.12.006_bib0075","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMra071667","article-title":"Myocardial reperfusion injury","volume":"357","author":"Yellon","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2015.12.006_bib0080","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0891-5849(02)01179-6","article-title":"Nitroxyl affords thiol-sensitive myocardial protective effects akin to early preconditioning","volume":"34","author":"Pagliaro","year":"2003","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.phrs.2015.12.006_bib0085","doi-asserted-by":"crossref","first-page":"14617","DOI":"10.1073\/pnas.96.25.14617","article-title":"Opposite effects of nitric oxide and nitroxyl on postischemic myocardial injury","volume":"96","author":"Ma","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2015.12.006_bib0090","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1476-5381.2012.02176.x","article-title":"Reperfusion-induced myocardial dysfunction is prevented by endogenous annexin-A1 and its N-terminal-derived peptide Ac-ANX-A1(2\u201326)","volume":"168","author":"Qin","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2015.12.006_bib0095","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/cvr\/22.7.447","article-title":"The lambeth conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion","volume":"22","author":"Walker","year":"1988","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2015.12.006_bib0100","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1161\/01.HYP.0000072010.54901.DE","article-title":"NO\u2014activates soluble guanylate cyclase and Kv channels to vasodilate resistance arteries","volume":"41","author":"Irvine","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2015.12.006_bib0105","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1161\/01.HYP.0000259328.04159.90","article-title":"Nitroxyl anion donor, Angeli's salt, does not develop tolerance in rat isolated aortae","volume":"49","author":"Irvine","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2015.12.006_bib0110","doi-asserted-by":"crossref","first-page":"9196","DOI":"10.1073\/pnas.1430507100","article-title":"A biochemical rationale for the discrete behavior of nitroxyl and nitric oxide in the cardiovascular system","volume":"100","author":"Miranda","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2015.12.006_bib0115","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1172\/JCI28371","article-title":"Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels","volume":"116","author":"Stasch","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2015.12.006_bib0120","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.tips.2008.08.005","article-title":"Nitroxyl (HNO): the Cinderella of the nitric oxide story","volume":"29","author":"Irvine","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.phrs.2015.12.006_bib0125","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0003-9861(02)00031-0","article-title":"Further evidence for distinct reactive intermediates from nitroxyl and peroxynitrite: effects of buffer composition on the chemistry of Angeli's salt and synthetic peroxynitrite","volume":"401","author":"Miranda","year":"2002","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.phrs.2015.12.006_bib0130","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1089\/ars.2007.9.101","article-title":"The red wine antioxidant resveratrol prevents cardiomyocyte injury following ischemia-reperfusion via multiple sites and mechanisms","volume":"9","author":"Goh","year":"2007","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.phrs.2015.12.006_bib0135","first-page":"291","article-title":"Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats","volume":"148","author":"Hill","year":"1996","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.phrs.2015.12.006_bib0140","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.phrs.2012.07.010","article-title":"Endothelium-dependent nitroxyl-mediated relaxation is resistant to superoxide anion scavenging and preserved in diabetic rat aorta","volume":"66","author":"Leo","year":"2012","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2015.12.006_bib0145","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/0002-9149(80)90130-7","article-title":"Ineffectiveness of sublingual nitroglycerin in acute left ventricular failure in the presence of massive peripheral edema","volume":"45","author":"Magrini","year":"1980","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.phrs.2015.12.006_bib0150","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1161\/01.RES.85.11.1101","article-title":"The molecular basis for distinct beta-adrenergic receptor subtype actions in cardiomyocytes","volume":"85","author":"Steinberg","year":"1999","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2015.12.006_bib0155","doi-asserted-by":"crossref","first-page":"13150","DOI":"10.1021\/bi801925p","article-title":"Phospholamban thiols play a central role in activation of the cardiac muscle sarcoplasmic reticulum calcium pump by nitroxyl","volume":"47","author":"Froehlich","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.phrs.2015.12.006_bib0160","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1161\/01.RES.0000253904.53601.c9","article-title":"Nitroxyl improves cellular heart function by directly enhancing cardiac sarcoplasmic reticulum Ca2+ cycling","volume":"100","author":"Tocchetti","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2015.12.006_bib0165","doi-asserted-by":"crossref","first-page":"H939","DOI":"10.1152\/ajpheart.00630.2012","article-title":"Nitroxyl donors retain their depressor effects in hypertension","volume":"305","author":"Irvine","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.phrs.2015.12.006_bib0170","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1089\/ars.2010.3859","article-title":"Playing with cardiac redox switches: the HNO way to modulate cardiac function","volume":"14","author":"Tocchetti","year":"2011","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.phrs.2015.12.006_bib0175","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1161\/HYPERTENSIONAHA.114.04285","article-title":"Soluble guanylate cyclase is required for systemic vasodilation but not positive inotropy induced by nitroxyl in the mouse","volume":"65","author":"Zhu","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2015.12.006_bib0180","doi-asserted-by":"crossref","first-page":"H128","DOI":"10.1152\/ajpheart.00739.2005","article-title":"Ischemia\u2013reperfusion-induced calpain activation and SERCA2a degradation are attenuated by exercise training and calpain inhibition","volume":"290","author":"French","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.phrs.2015.12.006_bib0185","first-page":"H2025","article-title":"Modification of ischemia\u2013reperfusion-induced changes in cardiac sarcoplasmic reticulum by preconditioning","volume":"274","author":"Osada","year":"1998","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.phrs.2015.12.006_bib0190","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0022-3565(24)39198-0","article-title":"Effect of beta-adrenoceptor blockers on sarcoplasmic reticular function and gene expression in the ischemic-reperfused heart","volume":"293","author":"Temsah","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2015.12.006_bib0195","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/00005344-199104000-00017","article-title":"Cardiovascular responses to the stereoisomers of dobutamine in isolated rat hearts 48h after acute myocardial infarction","volume":"17","author":"Vleeming","year":"1991","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.phrs.2015.12.006_bib0200","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1001\/jama.297.17.1883","article-title":"Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE randomized Trial","volume":"297","author":"Mebazaa","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2015.12.006_bib0205","article-title":"Nitroxyl (HNO) stimulates soluble guanylyl cyclase to suppress cardiomyocyte hypertrophy and superoxide generation","volume":"4892","author":"Lin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2015.12.006_bib0210","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.freeradbiomed.2013.02.025","article-title":"Nitroxyl (HNO) suppresses vascular Nox2 oxidase activity","volume":"60","author":"Miller","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.phrs.2015.12.006_bib0215","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1089\/ars.2010.3838","article-title":"The chemistry of nitroxyl-releasing compounds","volume":"14","author":"DuMond","year":"2011","journal-title":"Antiox Redox Signal"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661815300323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661815300323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T23:51:27Z","timestamp":1748735487000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661815300323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":43,"alternative-id":["S1043661815300323"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2015.12.006","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The HNO donor Angeli\u2019s salt offers potential haemodynamic advantages over NO or dobutamine in ischaemia\u2013reperfusion injury in the rat heart ex vivo","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2015.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}